TrialClinical pharmacology in drug development2026
Steady-State Pharmacokinetic Properties of TNX-102 SL, a Sublingual Tablet Formulation of Cyclobenzaprine Hydrochloride (HCl), With Daily Dosing in Healthy Volunteers: A Randomized, Open-Label Trial.
Gregory M Sullivan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.